DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이윤희 | - |
dc.contributor.author | 김세미 | - |
dc.date.accessioned | 2020-09-11T01:56:14Z | - |
dc.date.available | 2020-09-11T01:56:14Z | - |
dc.date.issued | 2017-09-19 | - |
dc.identifier.other | 1009VUS-2 | - |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/20564 | - |
dc.description.abstract | As explained hereinbefore, the C12orf59 gene of the present invention suppresses cancer cell invasion and inhibits cancer cell survivability, and the over expression of C12orf59 protein or a fragment thereof inhibits cancer cell invasion, so that C12orf59 gene or a fragment thereof not only can be effectively used for the pharmaceutical composition for preventing and treating cancer but also can be used as a clinical marker for screening a cancer treatment agent candidate, for diagnosing various cancers or for predicting pathological stage. In addition, the C12orf59 gene or a fragment thereof of the present invention can be used for the method for preventing and treating cancer and for the preparation of a pharmaceutical composition for preventing and treating cancer. | - |
dc.title | C12orf59 유래 펩타이드를 유효성분으로 함유하는 암 예방 및 치료용 약학적 조성물 | - |
dc.title.alternative | Pharmacological composition containing C12orf59-derived peptides for the prevention and treatment of cancer | - |
dc.type | Patent | - |
dc.date.registration | 2017-09-19 | - |
dc.contributor.affiliatedAuthor | 이윤희 | - |
dc.contributor.affiliatedAuthor | 김세미 | - |
dc.date.application | 2015-03-20 | - |
dc.identifier.patentApplicationNumber | 14/664,048 | - |
dc.identifier.patentRegistrationNumber | 9,765,118 | - |
dc.publisher.location | 미국 | - |
dc.contributor.assignee | 한국생명공학연구원 | - |
dc.contributor.inventor | 김세미 | - |
dc.description.patentCountryDivision | 국외 | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.